The use of quantum computing in drug discovery is likely to improve the overall R&D productivity by providing better clinical outcomes with accurate predictions of a drug molecule's properties. Overall, this domain is anticipated to gain significant traction, in the foreseen future. Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery.
The financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:
§ Drug Discovery Service(s) Offered
§ Target Identification / Validation
§ Hit Generation / Lead Identification
§ Lead Optimization
§ Therapeutic Area
§ Cardiovascular Disorders
§ CNS Disorders
§ Dermatological Disorders
§ Endocrine Disorders
§ Gastrointestinal Disorders
§ Immunological Disorders
§ Infectious Diseases
§ Musculoskeletal Disorders
§ Oncological Disorders
§ Respiratory Disorders
§ Others
§ Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Latin America
§ MENA
The “Quantum Computing in Drug Discovery Services Market 2023-2035” report features the following companies, which we identified to be key players in this domain:
§ Accenture
§ Amazon Web Services
§ Atos
§ Fujitsu
§ Huawei
§ IBM
§ Microsoft
§ Xanadu
§ XtalPi
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Software Providers
5. Company Competitiveness Analysis
6. Company Profiles: Software Providers
7. Market Landscape: Hardware Providers
8. Company Profiles: Hardware Providers
9. Academic Grants Analysis
10. Partnerships and Collaborations
11. Use Case Study
12. Porter’s Five Forces Analysis
13. Blue Ocean Strategy
14. Market Sizing and Opportunity Analysis
15. Executive Insights
16. Appendix I- Tabulated Data
17 Appendix II- List of Companies
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Comments
0 comment